Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

Tan, Emily L.C.; Ooi, Eng Eong; Lin, Chin-Yo; Tan, Hwee Cheng; Ling, Ai Ee; Lim, Bing; Stanton, Lawrence W.

Back to Previous Page

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

Published Date:

Apr 2004

Source:

Emerg Infect Dis. 10(4):581-586.

[PDF-131.59 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Tan, Emily L.C. ; Ooi, Eng Eong ; Lin, Chin-Yo ; Tan, Hwee Cheng ; Ling, Ai Ee ; ... More ▼

Description:

Severe acute respiratory syndrome (SARS) is an infectious disease caused by a newly identified human coronavirus (SARS-CoV). Currently, no effective drug exists to treat SARS-CoV infection. In this study, we investigated whether a panel of commercially available antiviral drugs exhibit in vitro anti-SARS-CoV activity. A drug-screening assay that scores for virus-induced cytopathic effects on cultured cells was used. Tested were 19 clinically approved compounds from several major antiviral pharmacologic classes: nucleoside analogs, interferons, protease inhibitors, reverse transcriptase inhibitors, and neuraminidase inhibitors. Complete inhibition of cytopathic effects of SARS-CoV in culture was observed for interferon subtypes, b-1b, a-n1, a-n3, and human leukocyte interferon a. These findings support clinical testing of approved interferons for the treatment of SARS.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

File Type:

Supporting Files:

	03-0458-F1.gif	image/gif
	03-0458-F1.jpg	image/jpeg
	03-0458-F2.gif	image/gif
	03-0458-F2.jpg	image/jpeg
	03-0458.nxml	text/plain
	license.txt	text/plain

No Related Documents.

Preguntas frecuentes sobre el SRAS

[PDF - 259.23 KB]

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

2004/4/26

Series:

Síndrome respiratorio agudo severo
Severe acute respiratory syndrome

Description:

26 de abril del 2004Frequently asked questions about SARS [Spanish]El síndrome respiratorio agudo severo (SRAS) (en inglés: Severe Acute Respiratory...

File Type:

[PDF - 259.23 KB]

File Type:

[PDF - 259.23 KB]
SARS

[PDF - 81.29 KB]

Corporate Authors:

Centers for Disease Control and Prevention (U.S.). David J. Sencer CDC Museum.

Published Date:

10/28/09

Series:

Infectious disease trading cards ; series 1

Description:

Part of series 1 of the CDC Museum set of Infectious disease trading cards, featuring photos and information about some of the infectious diseases tha...

File Type:

[PDF - 81.29 KB]

File Type:

[PDF - 81.29 KB]
Severe Acute Respiratory Syndrome: Relapse? Hospital Infection?

[PDF - 161.18 KB]

Personal Author:

Tsang, Owen Tak-Yin ; Chau, Tai-Nin ; ...

Published Date:

Sep 2003

Source:

Emerg Infect Dis. 9(9):1180-1181.

File Type:

[PDF - 161.18 KB]

File Type:

[PDF - 161.18 KB]
Clinical Trials and Novel Pathogens: Lessons Learned from SARS

[PDF - 223.01 KB]

Personal Author:

Muller, Matthew P. ; McGeer, Allison ; ...

Published Date:

Mar 2004

Source:

Emerg Infect Dis. 10(3):389-394.

Description:

During the recent global outbreak of severe acute respiratory syndrome (SARS), thousands of patients received treatments of uncertain efficacy and kno...

File Type:

[PDF - 223.01 KB]

File Type:

[PDF - 223.01 KB]
Antiviral agents for the treatment and chemoprophylaxis of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP)

[PDF - 24.76 MB]

Personal Author:

Bresee, Joseph S. ; Fiore, Anthony E. ; ...

Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; National Center for Immunization and Respiratory Diseases (U.S.) ; ...

Published Date:

January 21, 2011

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 60, no. 1

Description:

"This report updates previous recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of antiviral agents for t...

Status:

current

File Type:

[PDF - 24.76 MB]

File Type:

[PDF - 24.76 MB]

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC